← Eichor
Study identifier: NCT02526095 Synced from ClinicalTrials.gov · July 28, 2026
● Recruiting

The French EsoGastricTumours Data Base

Condition: Esophageal Disease  ·  Sponsor: University Hospital, Lille

PhaseN/A
Planned participants15000
Who can joinAll sexes, 18 Years to 90 Years
Healthy volunteersNo

About this study

This retrospective study aims at evaluating the outcomes of gastrointestinal stromal tumor after surgery.

This description comes directly from the study's public registry record.

Talk to the study team

Guillaume Piessen, MD, PhD  ·  +3320444407  ·  guillaume.piessen@chru-lille.fr

Always discuss trial participation with your own doctor first.

Locations (31)

Chu Amiens PicardieAmiens, FranceRecruiting
Chru BesanconBesançon, FranceRecruiting
Hu Paris Site Avicenne AphpBobigny, FranceRecruiting
Chu de Caen NormandieCaen, FranceRecruiting
Crlcc Francois BaclesseCaen, FranceRecruiting
Hopital Estaing - Chu63 - Clermont FerrandClermont-Ferrand, FranceRecruiting
Hu Paris Nord Site Louis Mourier AphpColombes, FranceRecruiting
Hopital Le Bocage Chru DijonDijon, FranceRecruiting
Chu de Grenoble AlpesGrenoble, FranceRecruiting
Hop Claude Huriez Chu LilleLille, FranceRecruiting
Clcc Oscar Lambret LilleLille, FranceRecruiting
C H U Dupuytren LimogesLimoges, FranceRecruiting

+ 19 more locations — full list on the registry record.

Follow this study

Get one email when the public record changes — results posted, or the study's status changes. Nothing else, ever.

We email about this public record only. Unsubscribe anytime with one click. Never medical advice.

Is this your study? This page was generated automatically from the public registry record. Sponsors can claim it — free — to add branding and verified contact routing. Claim this page →

This page is independently generated by Eichor from the public ClinicalTrials.gov record and re-synced daily. It is not the sponsor's official website unless claimed. Nothing here is medical advice; eligibility is always determined by the study team — talk to your own doctor first.

Source record: clinicaltrials.gov/study/NCT02526095